Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial

Efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma: Protocol for a randomized controlled clinical trial

Background: Immune checkpoint inhibitor-induced immune-mediated hepatitis (ICI-IMH) in patients with hepatocellular carcinoma (HCC) has been established to increase the risk of liver failure (LF). Given the accumulating evidence supporting the efficacy of artificial liver support systems (ALSS) in m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qiumin Luo, Yeqiong Zhang, Zhipeng Li, Jia Chen, Zhexuan Deng, Jiadi Lai, Xiyao Chen, Chan Xie, Liang Peng, Ying Liu, Wenxiong Xu
Format:	Article
Language:	English
Published:	Elsevier 2024-10-01
Series:	Heliyon
Subjects:	Hepatocellular carcinoma Immune checkpoint inhibitors Liver failure Artificial liver support system Double plasma molecular adsorption system Plasma exchange
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024151262
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Development and validation of a novel prognostic nomogram for hepatitis B virus-related acute-on-chronic liver failure patients receiving artificial liver therapy
by: Xiaofang Wang, et al.
Published: (2024-11-01)

Severe liver injury induced by minocycline in hepatitis B patient: a Case Report
by: Ran Wang, et al.
Published: (2024-12-01)

Current trends in the treatment of liver abscesses
by: P. S. Bushlanov, et al.
Published: (2018-12-01)

Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
by: Parissa Tabrizian, et al.
Published: (2025-02-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Iodine-131 Combined With Plasma Exchange Treatment in Graves’ Hyperthyroidism Patients With Severe Liver Injury Whose Average Model for End-Stage Liver Disease Scores >20
by: Xin-Fang Zhu, et al.
Published: (2025-01-01)

Bibliometric analysis of immune checkpoint inhibitors to treat hepatocellular carcinoma in patients with liver transplantation
by: Yanjiao Ou, et al.
Published: (2025-01-01)

Transcatheter arterial chemoembolization of hepatocellular carcinoma on liver cirrhosis in patients awaiting liver transplantation
by: A. S. Polekhin, et al.
Published: (2021-04-01)

Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
by: Kazuo Tarao, et al.
Published: (2019-03-01)

Rethinking Immune Check Point Inhibitors Use in Liver Transplantation: Implications and ResistanceSummary
by: Vivian Ortiz, et al.
Published: (2025-01-01)

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
by: Zhang S, et al.
Published: (2025-02-01)

Platelet-rich plasma-derived extracellular vesicles improve liver cirrhosis in mice
by: Yuichirou Maeda, et al.
Published: (2024-06-01)

Liver Transplantation for Liver-Originated Malignancy: A Single Center Experience
by: Ramazan Kozan, et al.
Published: (2024-07-01)

Case report: A rare case of intragastric metastasis after liver transplantation for liver cancer
by: Youfeng Xue, et al.
Published: (2024-12-01)

DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases
by: Tina Draškovič, et al.
Published: (2024-11-01)

Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer
by: Jiahe Tian, et al.
Published: (2024-12-01)

Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
by: I. A. Goncharova, et al.
Published: (2023-03-01)

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
by: Melchor Alpízar Salazar, et al.
Published: (2025-01-01)

Long-Term Outcomes of Laparoscopic Anatomical versus Non-Anatomical Liver Resection for Hepatocellular Carcinoma
by: Leng S, et al.
Published: (2024-12-01)

Key Epigenetic Players in Etiology and Novel Combinatorial Therapies for Treatment of Hepatocellular Carcinoma
by: José Belizário, et al.
Published: (2024-11-01)

Pathogenesis and management of metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma: a narrative review
by: Han Ah Lee
Published: (2024-10-01)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
by: Kyunghye Bang, et al.
Published: (2023-02-01)

Median Meld at Transplant Minus 3 Reduces the Mortality of Non-Hepatocellular Carcinoma Patients on the Liver Transplant Waitlist
by: Panthea Pouramin, et al.
Published: (2024-11-01)

The impact of fasting toward oxidative stress marker in the liver and plasma of new zealand white rabbit
by: Novi Silvia Hardiany, et al.
Published: (2022-11-01)

A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing
by: Karina Benderski, et al.
Published: (2025-01-01)

Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis
by: Laura Burke, et al.
Published: (2025-01-01)

Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level
by: Monika Pazgan-Simon, et al.
Published: (2024-10-01)

A Rare Case of Post-Partum Hemorrhage with Refractory Thrombotic Microangiopathy, and Hepatic Infarction: A Diagnostic Dilemma with High Mortality
by: Naved Yousuf Hasan, et al.
Published: (2022-12-01)

Low functional liver imaging score is associated with poor prognosis following hepatectomy for hepatocellular carcinoma
by: Nozomu Sakai, et al.
Published: (2024-12-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Impact of postoperative morbidity on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: a multicenter observational study
by: Shiye Yang, et al.
Published: (2025-01-01)

The histopathological and molecular heterogeneity of hepatocellular carcinoma: a narrative review
by: Wonju Chung, et al.
Published: (2024-10-01)

Differentiating Liver Metastases from Primary Liver Cancer: A Retrospective Study of Imaging and Pathological Features in Patients with Histopathological Confirmation
by: Laura Andreea Ghenciu, et al.
Published: (2025-01-01)

Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
by: Yeshong Park, et al.
Published: (2024-12-01)

Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study
by: Zhan-Cheng Qiu, et al.
Published: (2025-01-01)

Drug-induced Liver Injury from Intravenous Immunoglobulin for Prevention of Recurrent Gestational Alloimmune Liver Disease: A Clinical Catch-22
by: Jessica A. Meyer, et al.
Published: (2024-07-01)

Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B
by: Gi-Ae Kim, et al.
Published: (2024-10-01)

Hepatocellular carcinoma in a van cat
by: Zabid Yener, et al.

Synergistic SDT/cuproptosis therapy for liver hepatocellular carcinoma: enhanced antitumor efficacy and specific mechanisms
by: Yucao Sun, et al.
Published: (2024-12-01)

Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
by: Davide Misceo, et al.
Published: (2024-12-01)